发明名称 |
METHOD AND COMPOSITION FOR DIAGNOSIS OR TREATMENT OF AGGRESSIVE PROSTATE CANCER |
摘要 |
Methods, pharmaceutical formulations and medicaments for treating prostate cancer or preventing the progression of a nonaggressive form of prostate cancer to an aggressive form, in a mammal, include a therapeutically effective amount of one or more active agents that reduce the expression or biological activity of both Forkhead box protein M1 (FOXM1) and Centromere protein F (CENPF) or biologically active fragments thereof or biologically active fragments thereof selected from the group consisting of an isolated shRNA, siRNA, antisense RNA, antisense DNA, Chimeric Antisense DNA/RNA, microRNA, and ribozymes that are sufficiently complementary to either a gene or an mRNA encoding either FOXM1 or CENPF proteins. A method is also presented for discovering synergistic master regulators of other phenotype transitions, wherein the master regulators are conserved among different species. |
申请公布号 |
US2017051281(A1) |
申请公布日期 |
2017.02.23 |
申请号 |
US201515119608 |
申请日期 |
2015.02.19 |
申请人 |
The Trustees of Columbia University in the City of New York |
发明人 |
ABATE-SHEN Corinne;CALIFANO Andrea;SHEN Michael |
分类号 |
C12N15/113;G06F19/22;G06F19/18 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating prostate cancer or preventing the progression of a nonaggressive form of prostate cancer to an aggressive form, in a mammal, comprising administering to the mammal a therapeutically effective amount of one or more active agents that reduce the expression or biological activity of both Forkhead box protein M1 (FOXM1) (SEQ ID NO: 50) and Centromere protein F (CENPF) (SEQ ID NO: 54) or biologically active fragments thereof or biologically active fragments thereof selected from the group consisting of an isolated shRNA, siRNA, antisense RNA, antisense DNA, Chimeric Antisense DNA/RNA, microRNA, and ribozymes that are sufficiently complementary to either a gene or an mRNA encoding either FOXM1 or CENPF proteins. |
地址 |
New York NY US |